All
Search
Images
Videos
Shorts
Maps
News
More
Shopping
Flights
Travel
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Treaty Treatment Health Grounds
Tt0323917
BCR-ABL1
CML Treatment
CYT387
Bosutinib
Dasatinib
CML 5Six
Carfilzomib
Harry Erba
Chronic Myeloid Leukemia Treatment Drugs
Dr Hologram
Dr. Cortes
Crizotinib
Blinatumomab in CADD Pump
Dr. Jorge Cortes
Chronic Myeloid Leukemia
Ariad
Axitinib
Imatinib Mesylate 400Mg
Cell Line
Iclusig
Pirtobrutinib vs Acalabrutinib
Chronic Myeloid Leukaemia
CML Cancer
Hagop M Kantarjian Sellas Life Sciences
Augmented Reality AR App
Monotherapy
Cvad
Is Parsley Good to Eat for CML Patients
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
Treaty Treatment Health Grounds
Tt0323917
BCR-ABL1
CML Treatment
CYT387
Bosutinib
Dasatinib
CML 5Six
Carfilzomib
Harry Erba
Chronic Myeloid Leukemia Treatment Drugs
Dr Hologram
Dr. Cortes
Crizotinib
Blinatumomab in CADD Pump
Dr. Jorge Cortes
Chronic Myeloid Leukemia
Ariad
Axitinib
Imatinib Mesylate 400Mg
Cell Line
Iclusig
Pirtobrutinib vs Acalabrutinib
Chronic Myeloid Leukaemia
CML Cancer
Hagop M Kantarjian Sellas Life Sciences
Augmented Reality AR App
Monotherapy
Cvad
Is Parsley Good to Eat for CML Patients
Philadelphia Chromosome
Peter Choi
Pace Trial
Fabrizio Pane
Ponatinib
Side Effects
Targeted Oncology
Leucemia Mieloide
Thrombosis
Leucemia Cronica
Phase 2 Study
Steve O'Brien
Chemo Free
CVAD
Tablet Costs
Jorge Cortes
T315I
Lymphoblastic Leukaemia
Hologram Medicine
Michael Mauro
AR Augmented Reality App
Dr Deininger on Long-Term Outcomes With Ponatinib in T315I
…
Jun 20, 2024
onclive.com
Managing T315I Mutations in CML: Second Line Treatment Options -
…
Dec 20, 2024
onclive.com
4:38
Ponatinib: Overview, Mechanism of Action & Clinical Trials | Takeda O
…
May 18, 2020
oncologymedinfo.com
2:32
Dr Deininger on Long-Term Outcomes With Ponatinib in T315I
…
141 views
Jun 21, 2024
YouTube
OncLive
5:07
Case 2: Ponatinib for T315I-Mutated CML
502 views
Jun 4, 2019
YouTube
Targeted Oncology
6:51
Resistance to Targeted-TKI Treatment in Patients With CML
625 views
Jul 8, 2019
YouTube
Targeted Oncology
5:47
TKI chemotherapy and ponatinib improve survival outcomes in CM
…
2 views
3 weeks ago
YouTube
ecancer
3:54
Managing TKI Therapy in CML
188 views
Dec 22, 2017
YouTube
Targeted Oncology
2:23
5-year Data for Ponatinib in Pretreated CP-CML from the OPTI
…
Jan 23, 2025
onclive.com
1:01
Dr. Cortes Discusses Ponatinib as Initial Therapy for CML
418 views
Feb 5, 2013
YouTube
OncLive
0:15
Ponatinib, rotating 3D model of antineoplastic agents, seamless lo
…
Sep 10, 2024
Adobe
Сергей Шиманович
1:54
Targeting the T315I mutation with ponatinib to treat patients with R/
…
669 views
Dec 20, 2022
YouTube
VJHemOnc – Video Journal of Hematology & H…
1:57
Post-hoc analysis of OPTIC: patient responses to ponatinib by T315I m
…
106 views
Sep 15, 2023
YouTube
VJHemOnc – Video Journal of Hematology & H…
2:25
Dose Reduction and Third-Line Therapy for CML
105 views
Jan 22, 2018
YouTube
Targeted Oncology
24:30
Management of Thrombosis Risk with Ponatinib and other TKIs for
…
1.4K views
May 15, 2015
YouTube
HMP Global
2:49
Outcomes of patients with CML-CP treated with ponatinib vs 2G-TKIs i
…
336 views
Feb 10, 2023
YouTube
VJHemOnc – Video Journal of Hematology & H…
ASH 2025 Insights: 1st Results of the Ph3 GIMEMA ALL2820 Trial Co
…
120 views
5 months ago
vumedi.com
0:54
In the PhALLCON trial, laboratory evidence showed that the rate of
…
1.3K views
May 10, 2024
Facebook
JAMA
1:56
Dr. Cortes on Ponatinib in Patients with CML and Ph+ALL
478 views
Dec 10, 2012
YouTube
Targeted Oncology
[Hot Item] Ponatinib Intermediate CAS No.: 943320-61-4
2 months ago
made-in-china.com
4:44
Ponatinib in chronic-phase CML patients with prior second generat
…
382 views
Dec 7, 2020
YouTube
VJHemOnc – Video Journal of Hematology & H…
1:10
Recent Updates from the OPTIC Trial of Ponatinib in Resistant CML
487 views
7 months ago
YouTube
Fadi Haddad M.D.
2:51
The use of asciminib versus ponatinib for multiresistant CML
1.5K views
Oct 20, 2022
YouTube
VJHemOnc – Video Journal of Hematology & H…
2:20
ASH12: Experimental Ponatinib Overcomes Drug Resistance in CML
412 views
Dec 10, 2012
YouTube
MDedge: news and insights for busy physicians
3:51
Interim Data Analysis Suggests Ponatinib to be Favorable TKI Tre
…
150 views
Dec 15, 2020
YouTube
CheckRare
1:35
FLAG-IDA and ponatinib in blast phase CML: MATCHPOINT trial
401 views
Jan 24, 2020
YouTube
VJHemOnc – Video Journal of Hematology & H…
1:38
An update on the OPTIC study: adjusting the dose of ponatinib fo
…
116 views
Sep 17, 2024
YouTube
VJHemOnc – Video Journal of Hematology & H…
2:59
OPTIC 3-year update: dose-optimization of 3 starting doses o
…
81 views
Jan 3, 2023
YouTube
VJHemOnc – Video Journal of Hematology & H…
1:28
Dr Gesiotto on Optimal Ponatinib Dosing Strategies in CP-CML
29 views
1 month ago
YouTube
OncLive
2:13
The impact of ponatinib on conception and pregnancy outco
…
100 views
Dec 8, 2024
YouTube
VJHemOnc – Video Journal of Hematology & H…
See more videos
More like this
Feedback